Table 2 Treatment continuation and visual acuity change post-endophthalmitis
No. | diagnosis | Pathogen identified on culture samples | Treatment continuation post endophthalmitis | BCVA ETDRS letters before endophthalmitis | BCVA ETDRS letters at 1 year post endophthalmitis | BCVA ETDRS letters at 2 years post endophthalmitis | Treatment interval before endophthalmitis (weeks) | Treatment interval 1st year after endophthalmitis (weeks) | Treatment interval 2nd year after endophthalmitis (weeks) |
|---|---|---|---|---|---|---|---|---|---|
1 | Myopic CNV | Staphylococcus Epidermitis | Stopped due to disease quiescence | 0 | 65 | 55 | 4 | NA | NA |
2 | NVAMD | Staphylococcus Epidermitis | Continued treatment | 30 | 30 | 0 | 6 | 4 | 3 |
3 | RVO | Staphylococcus Epidermitis | Stopped due to disease quiescence | 0 | 60 | 60 | 10 | NA | NA |
4 | NVAMD | No growth | Continued treatment | 55 | 45 | 35 | 4 | 4 | 5 |
5 | NVAMD | No growth | Continued treatment | 0 | 0 | 0 | 4 | 5 | 6 |
6 | NVAMD | No growth | Stopped due to loss of vision | 0 | 0 | 0 | 8 | NA | NA |
7 | DME | No growth | Continued treatment | 70 | 50 | 50 | 4 | 4 | 4 |
8 | NVAMD | Staphylococcus Epidermidis | Stopped due to disease quiescence | 50 | 80 | 85 | 5 | NA | NA |
9 | NVAMD | Staphylococcus Epidermidis | Stopped due to disease quiescence | 55 | 50 | 55 | 4 | NA | NA |
10 | DME | Staphylococcus Epidermidis | Continued treatment | 60 | 60 | 65 | 4 | 4 | 4 |
11 | DME | Staphylococcus Epidermidis | Continued treatment | 65 | 50 | 70 | 4 | 4 | 4 |